March 4, 2025 - 19:56

FOA is set to transform its reverse mortgage business by bringing in seasoned fintech veterans who specialize in digital solutions. The company's strategic move aims to enhance the reverse mortgage experience for consumers, making it more accessible and user-friendly. With a focus on leveraging technology, FOA intends to streamline processes and improve customer engagement in an industry often viewed as complex and outdated.
The new executives are expected to drive innovation by introducing cutting-edge digital tools that simplify the application and approval processes. By targeting the untapped home equity market, FOA seeks to expand its reach and offer tailored solutions that meet the evolving needs of homeowners. This initiative comes at a time when many individuals are looking for ways to leverage their home equity to secure financial stability in retirement.
As FOA embarks on this journey, the emphasis will be on creating a seamless digital experience that empowers consumers, ultimately aiming to redefine the reverse mortgage landscape.
May 14, 2026 - 00:55
Aeluma Announces Third Quarter Fiscal 2026 Financial ResultsAeluma, Inc., a company specializing in compound semiconductor technologies, has released its financial results for the third quarter of fiscal year 2026. The report comes alongside several major...
May 13, 2026 - 11:31
MCK Q1 Deep Dive: Revenue Misses Analyst Expectations as Margin Initiatives ContinueHealthcare distributor McKesson reported first-quarter earnings that missed revenue expectations, though the company continued to push ahead with margin-focused initiatives. For the quarter ending...
May 12, 2026 - 23:07
Prudential Financial Declares Quarterly Dividend on Common StockNEWARK, N.J., May 12, 2026 -- Prudential Financial, Inc. has declared a quarterly dividend of $1.40 per share on its common stock. The payment is scheduled for June 11, 2026, and will go to...
May 12, 2026 - 03:06
Cellectis Reports First Quarter 2026 Financial ResultsCellectis has announced its financial results for the first quarter of 2026, alongside updates on its clinical pipeline and preclinical research programs. The company is advancing its pivotal...